Leucocytoclastic vasculitis: An update for the clinician

Scandinavian Journal of Rheumatology

Volumn 30, Issue 6, 2001, Pages 315-322

  Koutkia, P ^a   Mylonakis, E ^a   Rounds, S ^a   Erickson, A ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Autoimmune diseases; Leucocytoclastic; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IODIDE; PENICILLIN G; PHENOTHIAZINE; QUINOLONE DERIVATIVE; RETINOID; SULFONAMIDE; TETRACYCLINE;

ABDOMINAL PAIN; ANAPHYLACTOID PURPURA; ARTHRALGIA; BLOOD CELL COUNT; BLOOD CULTURE; BLOOD VESSEL INJURY; DISEASE SEVERITY; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; IMMUNE COMPLEX DISEASE; LEUKOCYTOCLASTIC VASCULITIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ELECTROPHORESIS; REVIEW; SKIN BIOPSY; VASCULITIS; WEGENER GRANULOMATOSIS;

AUTOIMMUNE DISEASES; BIOPSY, NEEDLE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULITIS, HYPERSENSITIVITY;

EID: 0035662326     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097401317148499     Document Type: Review

References (34)

1. Prognostic factors in leucocytoclastic vasculitis
2. Cutaneous leucocytoclastic vasculitis: A clinical and aetiological study
3. Cutaneous leucocytoclastic vasculitis: Serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate
4. Severe adverse cutaneous reactions to drugs
5. Cutaneous leucocytoclastic vasculitis
6. A clinical approach to systemic vasculitis
7. Necrotizing vasculitis
8. Leucocytoclastic vasculitis
9. Hypersensitivity angiitis
10. Clinical features and outcome of 95 patients with hypersensitivity vasculitis
11. Etiological factors and underlying conditions in patients with leucocytoclastic vasculitis
12. Cutaneous vasculitis: An unusual presentation of sarcoidosis in adulthood
13. Small-vessel vasculitis
14. Drug-induced cutaneous vasculitis
15. Idiopathic hypersensitivity vasculitis: Clinicopathologic correlation of 61 cases
16. Enhanced endothelium-dependent vasodilator responses in patients with systemic vasculitis
17. Adhesion molecule expression and endothelial cell activation in cutaneous leucocytoclastic vasculitis
18. Pathogenesis of exercise-induced urticarial vasculitis lesions: Can the changes be extrapolated to all leucocytoclastic vasculitis lesions?
19. Level of cryoglobulins and leucocytoclastic vasculitis
20. Circulating myeloperoxidase and anti-myeloperoxidase antibody in patients with vasculitis
21. Clinical and histopathologic spectrum of necrotizing vasculitis
22. Primary systemic vasculitis
23. A palpable clue to vasculitis
24. Drug associated cutaneous vasculitis in adults in northwestern Spain
25. The dermal manifestatins of vasculitis. A clinical approach to diagnosis and treatment
26. Palpable purpura: An algorithmic approach
27. Cutaneous leucocytoclastic vasculitis: Clinical experience in 44 patients
28. Hypesensitivity vasculitis-not always benign?
29. Prognostic factors in leukocytoclastic vasculitis: A clinicopathologic study of 160 patients
30. Is it possible to offer evidence-based treatment for systemic vasculitis?
31. Cutaneous vasculitis: What have we learned in the past 20 years?
32. Neutrophilic vascular reactions
33. Serious and life-threatening drug eruptions
34. Cryoglobulinemic vasculitis resistant to intermittent intravenous pulse cyclophosphamide therapy